Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Inhibition of hepatitis C virus replication by peroxidation of arachidonate and restoration by vitamin E.

Huang H, Chen Y, Ye J.

Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18666-70. Epub 2007 Nov 14.

2.

Modulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin.

Pisonero-Vaquero S, García-Mediavilla MV, Jorquera F, Majano PL, Benet M, Jover R, González-Gallego J, Sánchez-Campos S.

Lab Invest. 2014 Mar;94(3):262-74. doi: 10.1038/labinvest.2013.156. Epub 2014 Feb 3.

3.

Ethanol enhances hepatitis C virus replication through lipid metabolism and elevated NADH/NAD+.

Seronello S, Ito C, Wakita T, Choi J.

J Biol Chem. 2010 Jan 8;285(2):845-54. doi: 10.1074/jbc.M109.045740. Epub 2009 Nov 12.

4.

[Inhibition of silent information regulator-1 in hepatocytes induces lipid metabolism disorders and enhances hepatitis C virus replication].

Sun LJ, Zhao YH, Li SC, Yu JW, Kang P, Liu W.

Zhonghua Gan Zang Bing Za Zhi. 2013 Nov;21(11):834-9. doi: 10.3760/cma.j.issn.1007-3418.2013.11.009. Chinese.

PMID:
24331693
5.

Valine, the branched-chain amino acid, suppresses hepatitis C virus RNA replication but promotes infectious particle formation.

Ishida H, Kato T, Takehana K, Tatsumi T, Hosui A, Nawa T, Kodama T, Shimizu S, Hikita H, Hiramatsu N, Kanto T, Hayashi N, Takehara T.

Biochem Biophys Res Commun. 2013 Jul 19;437(1):127-33. doi: 10.1016/j.bbrc.2013.06.051. Epub 2013 Jun 24.

PMID:
23806690
6.

Cytosolic phospholipase A2 gamma is involved in hepatitis C virus replication and assembly.

Xu S, Pei R, Guo M, Han Q, Lai J, Wang Y, Wu C, Zhou Y, Lu M, Chen X.

J Virol. 2012 Dec;86(23):13025-37. doi: 10.1128/JVI.01785-12. Epub 2012 Sep 26.

7.

ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.

Abe H, Imamura M, Hiraga N, Tsuge M, Mitsui F, Kawaoka T, Takahashi S, Ochi H, Maekawa T, Hayes CN, Tateno C, Yoshizato K, Murakami S, Yamashita N, Matsuhira T, Asai K, Chayama K.

J Hepatol. 2011 Jul;55(1):11-8. doi: 10.1016/j.jhep.2010.10.017. Epub 2010 Nov 29.

PMID:
21145867
8.

Inhibitory effects of Pycnogenol® on hepatitis C virus replication.

Ezzikouri S, Nishimura T, Kohara M, Benjelloun S, Kino Y, Inoue K, Matsumori A, Tsukiyama-Kohara K.

Antiviral Res. 2015 Jan;113:93-102. doi: 10.1016/j.antiviral.2014.10.017. Epub 2014 Nov 20.

PMID:
25446333
9.

Mitochondrial electron transport inhibition in full genomic hepatitis C virus replicon cells is restored by reducing viral replication.

Ando M, Korenaga M, Hino K, Ikeda M, Kato N, Nishina S, Hidaka I, Sakaida I.

Liver Int. 2008 Sep;28(8):1158-66. doi: 10.1111/j.1478-3231.2008.01720.x. Epub 2008 Apr 11.

PMID:
18410284
10.

Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells.

Choi J, Lee KJ, Zheng Y, Yamaga AK, Lai MM, Ou JH.

Hepatology. 2004 Jan;39(1):81-9.

PMID:
14752826
11.

Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.

Chang JH, Kato N, Muroyama R, Taniguchi H, Guleng B, Dharel N, Shao RX, Tateishi K, Jazag A, Kawabe T, Omata M.

Liver Int. 2010 Feb;30(2):311-8. doi: 10.1111/j.1478-3231.2009.02144.x. Epub 2009 Oct 16.

PMID:
19840259
12.

HIV infection of hepatocytes results in a modest increase in hepatitis C virus expression in vitro.

Kong L, Welge JA, Powell EA, Blackard JT.

PLoS One. 2014 Feb 28;9(2):e83728. doi: 10.1371/journal.pone.0083728. eCollection 2014.

13.

Viral evolution and interferon resistance of hepatitis C virus RNA replication in a cell culture model.

Sumpter R Jr, Wang C, Foy E, Loo YM, Gale M Jr.

J Virol. 2004 Nov;78(21):11591-604.

14.

Modulation of hepatitis C virus replication by iron and hepcidin in Huh7 hepatocytes.

Bartolomei G, Cevik RE, Marcello A.

J Gen Virol. 2011 Sep;92(Pt 9):2072-81. doi: 10.1099/vir.0.032706-0. Epub 2011 May 18.

PMID:
21593278
15.

Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinase.

Yano M, Ikeda M, Abe K, Kawai Y, Kuroki M, Mori K, Dansako H, Ariumi Y, Ohkoshi S, Aoyagi Y, Kato N.

Hepatology. 2009 Sep;50(3):678-88. doi: 10.1002/hep.23026.

PMID:
19492433
16.

A host cell RNA-binding protein, Staufen1, has a role in hepatitis C virus replication before virus assembly.

Blackham SL, McGarvey MJ.

J Gen Virol. 2013 Nov;94(Pt 11):2429-36. doi: 10.1099/vir.0.051383-0. Epub 2013 Aug 1.

PMID:
23907398
17.

A telomerase-derived peptide regulates reactive oxygen species and hepatitis C virus RNA replication in HCV-infected cells via heat shock protein 90.

Lee SA, Kim J, Sim J, Kim SG, Kook YH, Park CG, Kim HR, Kim BJ.

Biochem Biophys Res Commun. 2016 Feb 26;471(1):156-62. doi: 10.1016/j.bbrc.2016.01.160. Epub 2016 Jan 29.

PMID:
26828270
18.

[Inhibition of hepatitis C virus replication by mycophenolic acid in hepatocytes].

Chen H, Ye L, Su JM, Li Y, Zeng JR, Huo WZ.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2013 Feb;27(1):35-8. Chinese.

PMID:
23855126
19.

Increased susceptibility of Huh7 cells to HCV replication does not require mutations in RIG-I.

Feigelstock DA, Mihalik KB, Kaplan G, Feinstone SM.

Virol J. 2010 Feb 19;7:44. doi: 10.1186/1743-422X-7-44.

20.

Anti-HCV activities of selective polyunsaturated fatty acids.

Leu GZ, Lin TY, Hsu JT.

Biochem Biophys Res Commun. 2004 May 21;318(1):275-80. Erratum in: Biochem Biophys Res Commun. 2005 Apr 22;329(4):1360.

PMID:
15110784

Supplemental Content

Support Center